Login
Toggle navigation
Videos
Categories
Trending
Why Mayo Clinic for Cancer Treatment - Mayo Clinic/ Sameer R. Keole, M.D. Radiation Oncologist, mayo Clinic
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Why Mayo Clinic for Cancer Treatment - Mayo Clinic
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Alumni Insights: Drake's Journey to Investment Banking
00:10:00
Edward Jones 2024 Purpose, Inclusion, and Citizenship Report: Partnering for Positive Impact | Penny Pennington, Managing Partner , Edward Jones Investments.
00:10:00
Insights from Stephen Ambrosini of 20/20 Financial Advisers
00:10:00
How 529 Plans Can Impact Financial Aid and What You Need to Know
00:10:00
Creating impact at scale for the worlds largest and most influential corporations|Brendan Wallace,Managing Partner,Fifth Wall
00:10:00
Commitment to Quality, Innovation, Efficiency, and Safety in Geophysical Project Management
00:10:00
Kenneth Min-kyu Lee Pilots Kencoa Aerospace’s Growth in Manufacturing and Services | Kenneth Min-kyu Lee , CEO , Kencoa Aerospace Corp.
00:00:00
Neurologist and psychiatrist / Alice Weaver Flaherty, M.D., Ph.D.
00:10:00
Tan Sri Dato' Seri Vincent Tan, Founder and Advisor of Berjaya Corporation Berhad, was named the 2023 Malaysia Real Estate Personality of the Year.|Tan Sri Dato' Seri Vincent Tanis the founder of Berjaya Corporation Berhad
00:10:00
Key Drivers of Interest in Infrastructure Secondaries with Janice Ince | Janice Ince, Managing Director, Pantheon Ventures.
00:10:00
At the 25 Years MCI event, Christoph Vilanek of freenet AG and Thierry Bernard, CEO of QIAGEN N.V., engage in a distinguished guest live talk.
00:10:00
The International Investment Forum (IIF) offers insights on global investment trends and ideas across industries, sourced from top executives and managers worldwide.|James D. Calaway Executive Chairman of ioneer Ltd.